Abstract
Radiometals have become increasingly important because of their use both for diagnostic molecular imaging and therapy in Nuclear Medicine. The focus is on the study of biochemical processes at cellular and sub-cellular level in order to detect metabolic abnormalities associated with various diseases. For that purpose, molecules that selectively accumulate in the organ or tissue of interest by a specific mechanism such as receptor binding or interaction with biomolecules are labeled with 99mTc, 68Ga, 153Sm, 186/188Re, 177Lu, among others and used as radiopharmaceuticals. However, considerable effort is necessary to combine these radionuclides with biomolecules relevant to different pathological conditions. Intensive research on the coordination chemistry of these metals has led to novel labeling methods that yield stable compounds which retained the original biological activity of the ligand. Chemical aspects and clinical applications will be reviewed in this paper.
Keywords: Nuclear medicine, radiopharmaceuticals, metals, radionuclides, diagnosis, radiotherapy, Radiometal Complexes, Molecular Imaging, Therapeutic Nuclear Medicine, TECHNETIUM, Tc generator system, Tc-DTPA complex, technetium complexes, osteogenic activity, glucoheptonate, tartrate, Tc-ECD complex, Tc-MIBI, Tc-sestamibi, Tc-sestamibi complex, Tc-TRODAT-1, Technetium-HYNIC complex, Click Chemistry, somatostatine receptors, neurotensin, cholecystokinin-B/gastrin, RHENIUM, Rhenium compounds, Re, –, biphosphonates, (188Re-SOCTA-trastuzumab, poliaza macrocycles, DOTA-RGD, Ga-DOTA, (EC-MN), Zr-labeled Antibody
Current Medicinal Chemistry
Title: Radiometal Complexes in Molecular Imaging and Therapy
Volume: 17 Issue: 31
Author(s): A. M. Rey
Affiliation:
Keywords: Nuclear medicine, radiopharmaceuticals, metals, radionuclides, diagnosis, radiotherapy, Radiometal Complexes, Molecular Imaging, Therapeutic Nuclear Medicine, TECHNETIUM, Tc generator system, Tc-DTPA complex, technetium complexes, osteogenic activity, glucoheptonate, tartrate, Tc-ECD complex, Tc-MIBI, Tc-sestamibi, Tc-sestamibi complex, Tc-TRODAT-1, Technetium-HYNIC complex, Click Chemistry, somatostatine receptors, neurotensin, cholecystokinin-B/gastrin, RHENIUM, Rhenium compounds, Re, –, biphosphonates, (188Re-SOCTA-trastuzumab, poliaza macrocycles, DOTA-RGD, Ga-DOTA, (EC-MN), Zr-labeled Antibody
Abstract: Radiometals have become increasingly important because of their use both for diagnostic molecular imaging and therapy in Nuclear Medicine. The focus is on the study of biochemical processes at cellular and sub-cellular level in order to detect metabolic abnormalities associated with various diseases. For that purpose, molecules that selectively accumulate in the organ or tissue of interest by a specific mechanism such as receptor binding or interaction with biomolecules are labeled with 99mTc, 68Ga, 153Sm, 186/188Re, 177Lu, among others and used as radiopharmaceuticals. However, considerable effort is necessary to combine these radionuclides with biomolecules relevant to different pathological conditions. Intensive research on the coordination chemistry of these metals has led to novel labeling methods that yield stable compounds which retained the original biological activity of the ligand. Chemical aspects and clinical applications will be reviewed in this paper.
Export Options
About this article
Cite this article as:
M. Rey A., Radiometal Complexes in Molecular Imaging and Therapy, Current Medicinal Chemistry 2010; 17 (31) . https://dx.doi.org/10.2174/092986710793213733
DOI https://dx.doi.org/10.2174/092986710793213733 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Quinoline as a Privileged Scaffold in Cancer Drug Discovery
Current Medicinal Chemistry NO News is not Necessarily Good News in Cancer
Current Cancer Drug Targets Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside
Current Drug Targets Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer
Current Pharmaceutical Design PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design Outline of Proteins and Signaling Pathways Involved in Heart Failure
Current Protein & Peptide Science The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry Pleural Fluid Analysis for Evaluating Pleural Effusions
Current Respiratory Medicine Reviews In Silico Modeling of P450 Substrates, Inhibitors, Activators, and Inducers
Combinatorial Chemistry & High Throughput Screening Current Molecularly Targeting Therapies in NSCLC and Melanoma
Anti-Cancer Agents in Medicinal Chemistry Outcome-Dependent Global Similarity Analysis of Imbalanced Core Signaling Pathways in Ischemic Mouse Hippocampus
CNS & Neurological Disorders - Drug Targets Current Strategies for the Treatment of Ulcerative Colitis
Recent Patents on Inflammation & Allergy Drug Discovery Radiosensitization of Prostate Cancer by Soy Isoflavones
Current Cancer Drug Targets Kisspeptin: Paving the Way to a New Therapeutic Avenue in Reproduction
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Mucosal Healing in Crohn’s Disease: Relevance for Clinical Outcomes
Current Drug Targets Breast Cancer Therapy Based on Melatonin
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Novel Beta-Lactam Antibiotics Derivatives: Their New Applications as Gene Reporters, Antitumor Prodrugs and Enzyme Inhibitors
Mini-Reviews in Medicinal Chemistry Cutting Edge: Chemoprevention of Colorectal Neoplasia in Inflammatory Bowel Disease
Inflammation & Allergy - Drug Targets (Discontinued)